Notably, cognate CD4+ tumor-infiltrating lymphocytes (TILs) may directly kill MHC II+ tumor cells or limit tumor growth by promoting the functional conversion of protumor M2 macrophages to antitumor M1 macrophages. Here, CD4 is linked to neoplasm.